期刊文献+

健脾益髓方对胰腺癌化疗后骨髓抑制影响的临床观察 被引量:2

Clinical Study on the Effect of Jianpi Yisui Recipe on Myelosuppression inPatients with Pancreatic Cancer after Chemotherapy
下载PDF
导出
摘要 目的观察健脾益髓方对化疗后胰腺癌患者骨髓抑制的影响。方法回顾性分析2018年3月至2019年10月诸城中医医院化疗的胰腺癌患者90例,根据是否口服中药分为治疗组和对照组,各45例,两组患者均予以吉西他滨联合顺铂(GP)方案化疗,治疗组患者在化疗基础上给予健脾益髓方,对照组患者接受利血生进行治疗。比较分析治疗前后两组患者骨髓抑制指标WBC、HB、PLT的差异、中医症候改善情况、生活质量变化情况以及不良反应发生率。结果化疗第7天两组患者骨髓抑制指标均不同幅度下降,且治疗组低于对照组(P<0.05);第14天两组患者骨髓抑制指标均有不同幅度上升,治疗组高于对照组(P<0.05)。治疗组患者中医症候改善有效率高于对照组(P<0.05)。治疗组患者消化道反应(恶心、呕吐)发生率低于对照组(P<0.05)。两组患者肝肾功损害对比差异无统计学意义(P>0.05)。结论健脾益髓方联合化疗治疗晚期胰腺癌患者,能减轻化疗相关毒性反应,保护骨髓,改善患者生活质量。 Objective To observe the clinical effect of Jianpi Yisui Recipe on the prevention and treatment of myelosuppression after chemotherapy of pancreatic cancer.Methods From March 2018 to October 2019,90 patients with pancreatic cancer treated by chemotherapy in Zhucheng Hospital of traditional Chinese medicine were divided into treatment group and control group according to whether oral Chinese medicine was taken or not,45 cases in each group,both groups were treated with GP regimen chemotherapy,the treatment group was treated with Jianpi Yisui formula on the basis of chemotherapy,and the control group was treated with Lixuesheng.The difference of WBC,Hb and PLT,the improvement of TCM symptoms,the change of quality of life and the incidence of adverse reactions were compared before and after treatment.Results On the 7th day of chemotherapy,the bone marrow inhibition indexes of the two groups decreased in different ranges,and the treatment group was significantly lower than the control group(P<0.05);on the 14th day,the bone marrow inhibition indexes of the two groups increased in different ranges,and the treatment group was significantly higher than the control group(P<0.05).The effective rate of syndrome improvement in the treatment group was higher than that in the control group(P<0.05).The incidence of gastrointestinal reaction(nausea and vomiting)in the treatment group was lower than that in the control group(P<0.05).There was no significant difference between the two groups(P>0.05).Conclusion Jianpi Yisui decoction combined with chemotherapy can reduce chemotherapy-related toxicity,protect bone marrow and improve the quality of life of patients with advanced pancreatic cancer.
作者 姜峰 姜艳 赵伟汀 张洪燕 杨鹏 张燕 刘燕 JIANG Feng;JIANG Yan;ZHAO Weiting;ZHANG Hongyan;YANG Peng;ZHANG Yan;LIU Yan(Zhucheng Hospital of Traditional Chinese Medicine,Zhucheng,Shandong 262200,China;Zhucheng maternal and child health hospital,Zhucheng,Shandong 262200,China;Zhucheng Health and Epidemic Prevention Center,Zhucheng,Shandong 262200,China)
出处 《大医生》 2020年第5期82-85,共4页 Doctor
基金 2018年潍坊市中医药科研项目(编号:20182007)。
关键词 胰腺癌 健脾益髓方 化疗 骨髓抑制 pancreatic cancer Jianpi Yisui recipe chemotherapy myelosuppression
  • 相关文献

参考文献6

二级参考文献58

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1520
  • 2吴林生,陈亚男.周维顺教授论肺癌证治拾萃[J].中华中医药学刊,2007,25(2):213-215. 被引量:45
  • 3马科,马玲,施志明.原发性支气管肺癌中医证型规范化研究[J].辽宁中医杂志,2007,34(4):421-422. 被引量:38
  • 4Evans DB, Farnell MB, Lillemoe KD, et al. Surgical treatment of resectable and borderline reseetable pancreas cancer: expert consensus statement[J]. Ann Surg Oncol, 2009, 16(7): 1736-1744.
  • 5Winter M, Cameron ]L, Campbell KA, et al. 1423 panereaticodu- odenetomies for pancreatic cancer: a single-institution experience [J]. J Gastrointest Surg, 2006, 10(9): 1199- 1210.
  • 6Toomey P, Hernandez J, Morton C, et al. Resection of portovenous structures to obtain microscopically negative margins during pancre- aticoduodenectomy for pancreatic adenoeareinoma is worthwhile [ J ]. Am Surg, 2009, 75(9) : 804 -810.
  • 7Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease [J]. J Am Coll Surg, 2008, 206(5) : 833 -846.
  • 8Artinyan A, Anaya DA, Mckenzie S, et al. Neoadjuvant therapy is associated with improved survival in resectalbe pancreatic adenocar- cinoma[J]. Cancer, 2011, 117(10): 2044 -2049.
  • 9Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial[J].JAMA, 2007, 297(3) : 267 -277.
  • 10Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resec- ted pancreatic cancer: the CONKO-001 randomize trial[ J]. JAMA, 2013, 310(14) : 1473 - 1481.

共引文献33

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部